| T-Cell Prolymphocytic Leukemia studied in …STUDIED_INderived24 of 24show fewer |
|---|
| → studied in | NCT05010005Phase 1 · recruiting A Study of Ruxolitinib and Duvelisib in People With Lymphoma · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07311746Phase 1/Phase 2 · recruiting Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06810778Phase 1/Phase 2 · recruiting Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771572Phase 1 · recruiting Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356245Phase 2 · recruiting Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496349Phase 2 · recruiting A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL · condition mapped ALIAS · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512497Phase 1 · completed Romidepsin Maintenance After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05823571Phase 1 · active not recruiting Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05225584Phase 1 · completed Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04312841Phase 2 · completed Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526795Phase 1 · terminated Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia · condition mapped CURATED_BROADER · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06420076Phase 1/Phase 2 · recruiting Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989466Phase 1 · completed Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia · condition mapped CURATED_BROADER · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03873493Phase 2 · completed A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689453Phase 1 · completed Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186640Phase 2 · completed Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005803Phase 1/Phase 2 · completed Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251575Phase 2 · completed Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01008462Phase 2 · completed Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060424Phase 2 · completed Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742727Phase 1/Phase 2 · unknown CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749502Phase 1 · completed A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) · condition mapped ONTOLOGY_EXACT · 24 trials mapped (9 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |